Rare HCV subtypes and retreatment outcomes in a cohort of European DAA-experienced patients

Julia Dietz,Christiana Graf,Christoph P Berg,Kerstin Port,Katja Deterding,Peter Buggisch,Kai-Henrik Peiffer,Johannes Vermehren,Georg Dultz,Andreas Geier,Florian P Reiter,Tony Bruns,Jörn M Schattenberg,Elena Durmashkina,Thierry Gustot,Christophe Moreno,Janina Trauth,Thomas Discher,Janett Fischer,Thomas Berg,Andreas E Kremer,Beat Müllhaupt,Stefan Zeuzem,Christoph Sarrazin,C Antoni,A Teufel,R Vogelmann,M Ebert,J Balavoine,E Giostra,M Berning,J Hampe,T Boettler,C Neumann-Haefelin,R Thimme,A De Gottardi,A Rauch,N Semmo,V Ellenrieder,M Gress,A Herrmann,A Stallmach,D Hoffmann,U Protzer,A Kodal,M Löbermann,T Götze,V Keitel-Anselmino,C.M Lange,R Zachoval,J Mayerle,A Maieron,P Michl,U Merle,D Moradpour,J.-P Chave,M Muche,H.-J Epple,M Müller-Schilling,F Kocheise,T Müller,F Tacke,E Roeb,J Rissland,M Krawczyk,P Schulze,D Semela,U Spengler,J Rockstroh,C.P Strassburg,J Siebler,J Schulze Zur Wiesch,F Piecha,J Von Felden,S Jordan,A Lohse,M Sprinzl,P Galle,R Stauber,B Strey,W Steckstor,W Schmiegel,N.H Brockmeyer,A Canbay,C Trautwein,F Uschner,J Trebicka,T Weber,H Wedemeyer,M Cornberg,M Manns,P Wietzke-Braun,R Günther,K Willuweit,G Hilgard,H Schmidt,E Zizer,J Backhus,T Seufferlein,O Al-Taie,W Angeli,S Beckebaum,A Erhardt,A Garrido-Lüneburg,H Gattringer,D Genné,M Gschwantler,F Gundling,S Hametner,R Schöfl,S Haag,H Heinzow,T Heyer,C Hirschi,A Jussios,S Kanzler,N Kordecki,M Kraus,U Kullig,S Wollschläger,L Magenta,B Terziroli Beretta-Piccoli,M Menges,L Mohr,K Muehlenberg,C Niederau,B Paulweber,A Petrides,M Pinkernell,R Piso,W Rambach,L Reinhardt,M Reiser,B Riecken,A Rieke,J Roth,M Schelling,P Schlee,A Schneider,D Scholz,E Schott,M Schuchmann,U Schulten-Baumer,A Seelhoff,A Stich,F Stickel,J Ungemach,E Walter,A Weber,H Wege,T Winzer,W Abels,M Adler,F Audebert,C Baermann,E Bästlein,R Barth,K Barthel,W Becker,J Behrends,J Benninger,F Berger,D Berzow,T Beyer,M Bierbaum,O Blaukat,A Bodtländer,G Böhm,N Börner,U Bohr,B Bokemeyer,H.R Bruch,D Bucholz,P Buggisch,K Matschenz,J Petersen,O Burkhard,N Busch,C Chirca,R Delker,J Diedrich,M Frank,M Diehl,A.O Tal,M Schneider,A Dienethal,P Dietel,N Dikopoulos,M Dreck,F Dreher,L Drude,K Ende,U Ehrle,K Baumgartl,F Emke,R Glosemeyer,G Felten,D Hüppe,J Fischer,U Fischer,D Frederking,B Frick,G Friese,B Gantke,P Geyer,H.R Schwind,M Glas,T Glaunsinger,F Goebel,U Göbel,B Görlitz,R Graf,H Gruber,C Hartmann,C Klag,G Härter,M Herder,T Heuchel,S Heuer,H Hinrichsen,B Seegers,K.-H Höffl,H Hörster,J.-U Sonne,W.P Hofmann,F Holst,M Hunstiger,A Hurst,E Jägel-Guedes,C John,M Jung,B Kallinowski,B Kapzan,W Kerzel,P Khaykin,M Klarhof,U Klüppelberg,Wolfratshausen Wolfratshausen,K Klugewitz,B Knapp,U Knevels,T Kochsiek,A Körfer,A Köster,M Kuhn,A Langekamp,B Künzig,R Link,M Littman,H Löhr,T Lutz,P Gute,G Knecht,U Lutz,D Mainz,I Mahle,P Maurer,S Mauss,C Mayer,H Möller,R Heyne,D Moritzen,M Mroß,M Mundlos,U Naumann,O Nehls,K K,R Ningel,A Oelmann,H Olejnik,K Gadow,E Pascher,A Philipp,M Pichler,F Polzien,R Raddant,M Riedel,S Rietzler,M Rössle,W Rufle,A Rump,C Schewe,C Hoffmann,D Schleehauf,W Schmidt,G Schmidt-Heinevetter,J Schmidtler-Von Fabris,L Schneider,A Schober,S Niehaus-Hahn,J Schwenzer,T Seidel,G Seitel,C Sick,K Simon,D Stähler,F Stenschke,H Steffens,K Stein,M Steinmüller,T Sternfeld,K Svensson,W Tacke,G Teuber,K Teubner,J Thieringer,A Tomesch,U Trappe,J Ullrich,G Urban,S Usadel,A Von Lucadou,F Weinberger,M Werheid-Dobers,P Werner,T Winter,E Zehnter,A Zipf

doi:10.1016/j.jhepr.2024.101072

Abstract

Rare HCV subtypes and retreatment outcomes in a cohort of European DAA-experienced patients

Full Text

Published version (

Free)

Open DOI Link

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

R Discovery Prime

R Discovery Prime

Rare HCV subtypes and retreatment outcomes in a cohort of European DAA-experienced patients

Abstract

Talk to us

Similar Papers

More From: JHEP Reports

Lead the way for us

Journal: JHEP Reports	Publication Date: Mar 1, 2024
License type: cc-by-nc-nd

Similar Papers

P-219 - Gemcitabine and nab-paclitaxel based regimen in advanced pancreatic carcinoma at tertiary cancer centre, Bangalore
Satheesh Thungappa ... Ravi Thippeswamy
Annals of Oncology | VOL. 28
Satheesh Thungappa, et. al.Satheesh Thungappa ... Ravi Thippeswamy
01 Jun 2017
Annals of Oncology | VOL. 28

Resistance-associated substitutions in patients with chronic hepatitis C virus genotype 4 infection.
Christoph Welsch ... Darius Moradpour
Journal of viral hepatitis | VOL. 27
Christoph Welsch, et. al.Christoph Welsch ... Darius Moradpour
26 Jun 2020
Journal of viral hepatitis | VOL. 27

Describing the value of the most common first line NSCLC regimens in a real world setting.
Stephanie Korrer ... Thomas Horstman
Journal of Clinical Oncology | VOL. 35
Stephanie Korrer, et. al.Stephanie Korrer ... Thomas Horstman
20 May 2017
Journal of Clinical Oncology | VOL. 35

Prednisone, Vinblastine, Doxorubicin and Bendamustine (PVAB) Regimen in First Line Therapy for Older Patients with Advanced-Stage Classical Hodgkin Lymphoma: Results of a Prospective Multicenter Phase II Trial of the Lymphoma Study Association (LYSA)
Franck Morschhauser ... Christophe Bonnet
Blood | VOL. 134
Franck Morschhauser, et. al.Franck Morschhauser ... Christophe Bonnet
13 Nov 2019
Blood | VOL. 134

Editage

Paperpal

R Discovery

Mind the Graph

R Discovery Prime

R Discovery Prime

Rare HCV subtypes and retreatment outcomes in a cohort of European DAA-experienced patients

Abstract

Talk to us

Similar Papers

More From: JHEP Reports